Evidence map›Paper›PMID 29374060›Full record

ArticleThe Journal of biological chemistry2018

Jie Zhang, Zhi-Wei Ye, Wei Chen, Yefim Manevich, Shikhar Mehrotra, Lauren Ball, Yvonne Janssen-Heininger, Kenneth D Tew, Danyelle M Townsend

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Redox pathways in melanoma.Advances in cancer research · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Jie ZhangFrom the Departments of Cell and Molecular Pharmacology and Experimental Therapeutics.
Zhi-Wei YeFrom the Departments of Cell and Molecular Pharmacology and Experimental Therapeutics.
Wei ChenDepartment of Infectious Disease, the Second Affiliated Hospital of Medical School of the Southeast University, 1-1 Zhongfu Road, Nanjing 210003, China, and.
Yefim ManevichFrom the Departments of Cell and Molecular Pharmacology and Experimental Therapeutics.
Shikhar MehrotraSurgery, Medical University of South Carolina, Charleston, South Carolina 29425.
Lauren BallFrom the Departments of Cell and Molecular Pharmacology and Experimental Therapeutics.
Yvonne Janssen-HeiningerDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, Vermont 05405.
Kenneth D TewFrom the Departments of Cell and Molecular Pharmacology and Experimental Therapeutics, tewk@musc.edu.
Danyelle M TownsendPharmaceutical and Biomedical Sciences, and.
Medical University of South Carolina · USSoutheast University · CNUniversity of Vermont · US

Funding

SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALINGP20GM103542 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TEW, KENNETH D. · 2012 to 2020
$20.2M
S-glutathionylation chemistry in fibrotic lung remodelingR35HL135828 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI JANSSEN-HEININGER, YVONNE M. W. · 2017 to 2023
$6.5M
GLUTATHIONE S TRANSFERASES IN DRUG AND STRESS RESPONSER01CA085660 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TEW, KENNETH D. · 2000 to 2014
$5.0M
SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALINGP20RR024485 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TEW, KENNETH D. · 2011 to 2011
$2.2M
MUSC FACIL EXPANSION &RENOV: SLE C06RR015455 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CROUCH, ROSALIE K · 2002 to 2002
$2.0M
Orbitrap Mass SpectrometerS10OD010731 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BALL, LAUREN ELIZABETH · 2012 to 2012
$600k
PRECLINICAL DEVELOPMENT OF A GLUTATHIONE BASED CANCER DRUGR41CA117259 · NCI · CELLECTAR BIOSCIENCES, INC. · PI TEW, KENNETH D. · 2007 to 2007
$150k
NCI NIH HHS R01 CA085660NCI NIH HHS R41 CA117259NCRR NIH HHS C06 RR015455NCRR NIH HHS P20 RR024485NHLBI NIH HHS R35 HL135828NIGMS NIH HHS P20 GM103542NIH HHS S10 OD010731
6 · The paper itself

Abstract

Glutathione

Indexed as

Protein Processing, Post-TranslationalAnimalsCell ProliferationDendritic CellsEstrogen Receptor alphaGlutathioneGlutathione S-Transferase piMiceMice, Inbred C57BLMice, KnockoutOxidative StressReactive Oxygen SpeciesSignal TransductionEstrogen Receptor alphaGlutathioneGlutathione S-Transferase piGstp1 protein, mouseGstp2 protein, mouseReactive Oxygen Speciesdendritic cellenergy metabolismestrogenestrogen receptorglutathioneglutathione S-transferasemyeloproliferationredox signalingS-glutathionylation

Identifiers

PMID29374060
PMCPMC5868252
OpenAlexW2784690678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.